Fig. 4. Nerve conduction blockade prevents p38 activation in spinal microglia. Immunofluorescence shows phospho-p38 (p-p38) immunoreactivity in the spared nerve injury (SNI) rats (  A ) and SNI rats receiving nerve blockade (  B ).  Scale , 20 μm. (  C ) Number of p-p38–immunoreactive cells in the medial superficial (laminae I–III) spinal cord with pretreatment of bupivacaine microspheres. **  P < 0.01, compared with sham controls; ##  P < 0.01, compared with SNI, analysis of variance; n = 4. Sham control rats were given vehicle (fibrin solution of microspheres). SNI rats were given vehicle before SNI. Bupivacaine microspheres were applied before SNI. 

Fig. 4. Nerve conduction blockade prevents p38 activation in spinal microglia. Immunofluorescence shows phospho-p38 (p-p38) immunoreactivity in the spared nerve injury (SNI) rats (  A ) and SNI rats receiving nerve blockade (  B ).  Scale , 20 μm. (  C ) Number of p-p38–immunoreactive cells in the medial superficial (laminae I–III) spinal cord with pretreatment of bupivacaine microspheres. **  P < 0.01, compared with sham controls; ##  P < 0.01, compared with SNI, analysis of variance; n = 4. Sham control rats were given vehicle (fibrin solution of microspheres). SNI rats were given vehicle before SNI. Bupivacaine microspheres were applied before SNI. 

Close Modal

or Create an Account

Close Modal
Close Modal